My Financial News from Poland, Exchange rate

from Bing and Google News
Poland , Friday 17 April 2026

WPD Pharmaceuticals Enters into Amended and Restated Sublicense Agreement with Moleculin Biotech

Published on: Monday 24 January 2022

WPD Pharmaceuticals Inc. (the “Company” or “WPD”) (CSE: WBIO) (FSE: 8SV1), is pleased to announce that it has entered into an amended and restated sublicense agreement (the “Sublicense Agreement”) ...


News source: https://stockhouse.com/news/press-releases/2022/01/25/wpd-pharmaceuticals-enters-into-amended-and-restated-sublicense-agreement-with

Share this news on:  

RELATED NEWS

» 4Q21 “Consumption boom” in Poland and a hawkish central bank governor
» Poland reports new daily record of 57,659 COVID cases
» WPD Pharmaceuticals Enters into Amended and Restated Sublicense Agreement with Moleculin Biotech
» Nigerian Naira to Polish Zloty Spot Exchange Rates for 2022
» Is Poland Still the European Tiger in the Forex World?

HEADLINE NEWS